All Clinical Trials in Canada

A listing of 3905 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

Canada

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Phase I Trial of Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for Refractory Anorexia Nervosa With Comorbid Obsessive Compulsive Disorder or Major Depressive Disorder

NCT07113665

Recruiting

The goal of this clinical trial is to evaluate the safety and initial clinical effectiveness of MRI-guided focused ultrasound (MRgFUS) thermal ablation (capsulotomy) in patients with treatment-refractory anorexia nervosa (AN) and comorbid obsessive-compulsive disorder (OCD) and major depressive disorder (MDD). The main questions it aims to answer are: 1. Can MR-guided focused ultrasound capsulotomy be safely delivered through an intact skull in patients with treatment-refractory anorexia nervos... Read More

Gender:

ALL

Ages:

Between 18 years and 65 years

Trial Updated:

08/06/2025

Locations: Sunnybrook Health Sciences Centre, Toronto, Ontario

Conditions: Anorexia Nervosa (DSM-IV Revised Criteria)

Learn More ›

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)

NCT06687980

Recruiting

This is a parallel, Phase 3, 2-arm study for treatment. The purpose of this study is to measure improvement in pruritus with dupilumab subcutaneous injections compared with placebo injections in male and female participants aged at least 18 years with LSC. Study details include: The study duration will be up to 40 weeks. The treatment duration will be up to 24 weeks. The follow-up duration after treatment will be 12 weeks. The number of visits will be 6.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/06/2025

Locations: Center for Dermatology Clinical Research- Site Number : 8400226, Fremont, California +56 locations

Center for Dermatology Clinical Research- Site Number : 8400226, Fremont, California

Moore Clinical Research - Brandon- Site Number : 8400208, Brandon, Florida

Southern Indiana Clinical Research Center- Site Number : 8400230, Columbus, Indiana

Clinical Research of Philadelphia- Site Number : 8400215, Philadelphia, Pennsylvania

Austin Institute for Clinical Research - Pflugerville- Site Number : 8400203, Pflugerville, Texas

Progressive Clinical Research - San Antonio- Site Number : 8400206, San Antonio, Texas

Investigational Site Number : 0320204, Berazategui, Buenos Aires

Investigational Site Number : 0320202, San Miguel de Tucumán, Tucumán

Investigational Site Number : 0320201, Buenos Aires, Not set

Investigational Site Number : 0320203, Córdoba, Not set

Investigational Site Number : 0560202, Alken, Not set

Investigational Site Number : 1240210, Calgary, Alberta

Investigational Site Number : 1240207, Edmonton, Alberta

Investigational Site Number : 1240201, Surrey, British Columbia

Investigational Site Number : 1240205, London, Ontario

Investigational Site Number : 1240208, Markham, Ontario

Investigational Site Number : 1240209, Toronto, Ontario

Investigational Site Number : 1240203, Verdun, Quebec

Investigational Site Number : 1520202, Santiago, Reg Metropolitana De Santiago

Investigational Site Number : 1520201, Santiago, Reg Metropolitana De Santiago

Investigational Site Number : 1560204, Chongqing, Not set

Investigational Site Number : 1560206, Guangzhou, Not set

Investigational Site Number : 1560201, Guangzhou, Not set

Investigational Site Number : 1560202, Guangzhou, Not set

Investigational Site Number : 1560203, Wuhan, Not set

Investigational Site Number : 2030201, Prague, Not set

Investigational Site Number : 2030202, Prague, Not set

Investigational Site Number : 2030203, Prague, Not set

Investigational Site Number : 2760201, Berlin, Not set

Investigational Site Number : 2760202, Frankfurt, Not set

Investigational Site Number : 2760205, Hamburg, Not set

Investigational Site Number : 2760203, Kiel, Not set

Investigational Site Number : 3000203, Athens, Not set

Investigational Site Number : 3000201, Athens, Not set

Investigational Site Number : 3000202, Ioannina, Not set

Investigational Site Number : 3480202, Orosháza, Not set

Investigational Site Number : 3480201, Pecs, Not set

Investigational Site Number : 3800201, Naples, Napoli

Investigational Site Number : 3800202, Rome, Roma

Investigational Site Number : 4100202, Ansan-si, Gyeonggi-do

Investigational Site Number : 4100203, Bupyeong-gu, Incheon-gwangyeoksi

Investigational Site Number : 4100201, Seoul, Seoul-teukbyeolsi

Investigational Site Number : 4100204, Seoul, Seoul-teukbyeolsi

Investigational Site Number : 4840201, Guadalajara, Jalisco

Investigational Site Number : 4840202, Monterrey, Nuevo León

Investigational Site Number : 4840203, Mérida, Yucatán

Investigational Site Number : 7240203, Pozuelo de Alarcón, Madrid

Investigational Site Number : 7240204, Alicante, Not set

Investigational Site Number : 7240202, Madrid, Not set

Investigational Site Number : 7240201, Madrid, Not set

Investigational Site Number : 1580203, Hsinchu, Not set

Investigational Site Number : 1580202, Taichung, Not set

Investigational Site Number : 1580201, Taoyuan City, Not set

Investigational Site Number : 7920202, Gaziantep, Not set

Investigational Site Number : 7920201, Istanbul, Not set

Investigational Site Number : 7920203, Istanbul, Not set

Investigational Site Number : 8260201, Southampton, Hampshire

Conditions: Lichen Simplex Chronicus

Learn More ›

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)

NCT06687967

Recruiting

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/06/2025

Locations: Dermatology Research Associates - Los Angeles- Site Number : 8400004, Los Angeles, California +56 locations

Dermatology Research Associates - Los Angeles- Site Number : 8400004, Los Angeles, California

Michigan Center for Research Company- Site Number : 8400013, Clarkston, Michigan

Equity Medical- Site Number : 8400017, New York, New York

Red River Research Partners - Fargo- Site Number : 8400007, Fargo, North Dakota

MedCare Pharma - Houston - Cypress Creek Parkway- Site Number : 8400014, Houston, Texas

Care Access - Arlington- Site Number : 8400022, Arlington, Virginia

Investigational Site Number : 0320003, Rosario, Santa Fe

Investigational Site Number : 0320001, Buenos Aires, Not set

Investigational Site Number : 0320004, Buenos Aires, Not set

Investigational Site Number : 0320002, Mendoza, Not set

Investigational Site Number : 1240005, Edmonton, Alberta

Investigational Site Number : 1240001, London, Ontario

Investigational Site Number : 1240007, Mississauga, Ontario

Investigational Site Number : 1240009, Montreal, Quebec

Investigational Site Number : 1240008, Québec City, Quebec

Investigational Site Number : 1240010, Regina, Saskatchewan

Investigational Site Number : 1240002, Saskatoon, Saskatchewan

Investigational Site Number : 1520002, Santiago, Reg Metropolitana De Santiago

Investigational Site Number : 1520001, Santiago, Reg Metropolitana De Santiago

Investigational Site Number : 1520003, Santiago, Reg Metropolitana De Santiago

Investigational Site Number : 1560002, Beijing, Not set

Investigational Site Number : 1560004, Hangzhou, Not set

Investigational Site Number : 1560001, Shanghai, Not set

Investigational Site Number : 1560003, Shijiazhuang, Not set

Investigational Site Number : 1560005, Suzhou, Not set

Investigational Site Number : 2030001, Ostrava, Not set

Investigational Site Number : 2760003, Bad Bentheim, Not set

Investigational Site Number : 2760002, Lübeck, Not set

Investigational Site Number : 2760001, Magdeburg, Not set

Investigational Site Number : 3000001, Athens, Not set

Investigational Site Number : 3000002, Thessaloniki, Not set

Investigational Site Number : 3000003, Thessaloniki, Not set

Investigational Site Number : 3480001, Debrecen, Not set

Investigational Site Number : 3480002, Kaposvár, Not set

Investigational Site Number : 3800001, Rome, Roma

Investigational Site Number : 3800002, Bologna, Not set

Investigational Site Number : 3920002, Ebina-shi, Kanagawa

Investigational Site Number : 3920001, Kamiamakusa, Kumamoto

Investigational Site Number : 3920007, Sakai, Osaka

Investigational Site Number : 3920003, Tachikawa, Tokyo

Investigational Site Number : 3920009, Fukuoka, Not set

Investigational Site Number : 3920005, Kagoshima, Not set

Investigational Site Number : 4840001, Chihuahua, Not set

Investigational Site Number : 6200002, Coimbra, Not set

Investigational Site Number : 6200003, Lisbon, Not set

Investigational Site Number : 6200001, Porto, Not set

Investigational Site Number : 7240003, Barcelona, Barcelona [Barcelona]

Investigational Site Number : 7240005, Barcelona, Catalunya [Cataluña]

Investigational Site Number : 7240002, Barcelona, Catalunya [Cataluña]

Investigational Site Number : 7240004, Valencia, Not set

Investigational Site Number : 1580002, Kaohsiung City, Not set

Investigational Site Number : 1580001, Taipei City, Not set

Investigational Site Number : 7920003, Adapazari, Not set

Investigational Site Number : 7920002, Istanbul, Not set

Investigational Site Number : 7920001, Samsun, Not set

Investigational Site Number : 8260002, Milton Keynes, Buckinghamshire

Investigational Site Number : 8260001, London, England

Conditions: Lichen Simplex Chronicus

Learn More ›

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

NCT05457283

Recruiting

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney disease, and proteinuria, a condition in which a person´s kidneys leak protein into the urine. The kidneys filter waste and fluid from the blood to form urine. In children with CKD, the kidney´s filters do not work as well as they should. This can lead to accumulation of waste and fluid in the body and proteinuria. CKD can lead to other medical problems, such as high blood pressure, also known as hypertension. Vice versa, hypertension and proteinuria can also contribute to worsening of CKD. Therefore, the treatment of CKD aims to control blood pressure and proteinuria. There are treatments available for doctors to prescribe to children with CKD and hypertension and/or proteinuria. These include "angiotensin-converting enzyme inhibitors" (ACEI) and "angiotensin receptor blockers" (ARB). Both ACEI and ARB can help improve kidney function by reducing the activity of the renin-angiotensin-aldosterone system (RAAS). The RAAS is a system that works with the kidneys to control blood pressure and the balance of fluid and electrolytes in the blood. In people with CKD, the RAAS is often too active, which can impair the ability of the kidneys to work properly and cause hypertension and proteinuria. However, ACEI or ARB treatment alone does not work for all patients with CKD as they only target the angiotensin part of the renin-angiotensin-aldosterone system. The study treatment, finerenone, is expected to help control RAAS overactivation together with an ACEI or ARB. So, the researchers in this study want to learn more about whether finerenone given in addition to either an ACEI or ARB can help their kidney function. The main purpose of this study is to learn how safe the treatment is when used of finerenone in addition to an ACEI or ARB in long-term. To see how safe the treatment is, the study team will collect information on medical problems which are also known as "treatment emergent adverse events" (TEAEs). And they will also collect levels of an electrolyte called potassium in the blood by taking blood samples, and measure blood pressure during the study. The secondary purpose of this study is to learn how well long-term use of finerenone can reduce the amount of protein in the participants' urine and benefit kidney function when taken with standard of care. To see how the treatment works, the study team will collect participants' urine samples to assess urinary albumin-to-creatinine ratio (UACR) and urinary protein-to-creatinine ratio (UPCR), which are important assessments for calculating the level of protein in the urine. Researchers will also collect blood samples to analyze serum creatinine and calculate estimated glomerular filtration rate (eGFR). A significant decline in eGFR indicates worsening kidney function. The study will include participants who had previously participated in FIONA study (NCT05196035). The participants will be aged from 1 year up to 18 years. The participants will be in the study for approximately 19 months. They will take study treatment for up to 18 months and will be follow up for 1 month. During this period, at least 12 visits are planned for patients who newly start finerenone, and at least 8 visits for patients who already received finerenone. In the visit, the study team will: * have their blood pressure, heart rate, temperature, height and weight measured * have blood and urine samples taken * have physical examinations * have their heart examined by an electrocardiogram and echocardiography (a sonogram of the heart) * answer questions about their medication and whether they have any adverse events, or have their parents or guardian's answer * answer questions about how they are feeling, or have their parents or guardian's answer * answer question about how they like the study medication, or have their parents or guardian's answer The doctors will keep track of any adverse events. An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events that happen in studies, even if they do not think the adverse events might be related to the study treatments. The doctors will check the participants' health about 30 days after the participants take their last treatment. Read Less

Gender:

ALL

Ages:

Between 1 year and 18 years

Trial Updated:

08/06/2025

Locations: Phoenix Children's Hospital | Main - Transplant Department, Phoenix, Arizona +164 locations

Phoenix Children's Hospital | Main - Transplant Department, Phoenix, Arizona

Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, California

Lucille Packard Children's Hospital Stanford - Pediatric Nephrology, Palo Alto, California

Rady Children's Hospital San Diego - Cardiology, San Diego, California

Children's National Medical Center - Nephrology, Washington, District of Columbia

Memorial Transplant Institute - Pediatric Nephrology, Hollywood, Florida

Emory University Hospital/Children's Healthcare of Atlanta - Nephrology, Atlanta, Georgia

University of Iowa Health Care Medical Center - Nephrology, Iowa City, Iowa

The Charlotte R. Bloomberg Children's Center Building - Nephrology, Baltimore, Maryland

Boston Children's Hospital - Main Campus - Nephrology, Boston, Massachusetts

Children's Mercy Hospital Kansas City - Nephrology, Kansas City, Missouri

Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati, Ohio

Cleveland Clinic | Pediatric Nephrology, Cleveland, Ohio

OHSU Doernbecher Children's Hospital - Neurology, Portland, Oregon

Children's Hospital of Philadelphia - Nephrology, Philadelphia, Pennsylvania

University Hospital - San Antonio - Pediatric Nephrology, San Antonio, Texas

Primary Children's Hospital, Salt Lake City, Utah

Seattle Children's Hospital - Nephrology, Seattle, Washington

Hospital de Niños Sor María Ludovica, La Plata, Buenos Aires

Hospital General de Ninos Ricardo Gutierrez | Pediatric Nephrology Department, Ciudad Autonoma de Buenos Aire, Ciudad Auton. De Buenos Aires

Centro de Rehabilitacion Cardiovascular | San Luis, Argentina, San Luis, Provincia De San Luis

Clinica de Nefrologia, Urologia y Enfermedades Cardiovascualares | Santa Fe, Argentina, Santa Fe, Provincia De Santa Fe

Hospital Italiano de Buenos Aires, Buenos Aires, Not set

Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Not set

Hospital General de Ninos Pedro de Elizalde | Nephrology Department, Ciudad Autonoma de Buenos Aire, Not set

Many Locations, Multiple Locations, Not set

Queensland Children's Hospital, South Brisbane, Queensland

Monash Children's Hospital, Clayton, Victoria

Royal Children's Hospital Melbourne, Parkville, Victoria

Kepler Universitätsklinikum Campus IV, Linz, Oberösterreich

Medizinische Universität Graz, Graz, Steiermark

Many Locations, Multiple Locations, Not set

Uniklinikum Salzburg - Landeskrankenhaus, Salzburg, Not set

Universitätsklinikum AKH Wien, Wien, Not set

Huderf / Ukzkf, Bruxelles - Brussel, Not set

CU Saint-Luc/UZ St-Luc, Bruxelles - Brussel, Not set

UZ Gent, Gent, Not set

UZ Gasthuisberg - Pediatric Nephrology, Leuven, Not set

CHC Montlégia - Pediatrics, Liège, Not set

Many Locations, Multiple Locations, Not set

Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Minas Gerais

Hospital Pequeno Principe, Curitiba, Parana

Hosp Clínicas Facult. Med. de Ribeirão Preto / USP, Ribeirão Preto/SP, Sao Paulo

Hospital PUC-Campinas | Centro de Pesquisa Clínica Sao Lucas, São Paulo, Sao Paulo

Hospital Infantil Sabará - Instituto PENSI - Pesquisa e Ensino em Saúde Infantil, Sao Paulo, SP

Instituto da Crianca e do Adolescente, Sao Paulo, Not set

UMHAT Sveti Georgi, Plovdiv, Not set

SHATPD "Prof. Ivan Mitev", Sofia, Not set

MHAT prof. Stoyan Kirkovitch AD, Stara Zagora, Not set

Alberta Children's Hospital - Nephrology Clinic, Calgary, Alberta

The Hospital for Sick Children (SickKids), Toronto, Ontario

CHU Sainte-Justine, Montreal, Quebec

Many Locations, Multiple Locations, Not set

Všeobecná fakultní nemocnice v Praze, Praha 2, Not set

Fakultní nemocnice v Motole, Praha 5, Not set

Rigshospitalet - Børn og Unge, Copenhagen, Not set

Many Locations, Multiple Locations, Not set

Odense Universitetshospital - HC Andersen Børne og Ungehospital, Odense C, Not set

Aarhus Universitetshospital - Børn og Unge, Århus N, Not set

Helsinki University Hospital | Children's Hospital - Clinical Trial Unit, Nephrology Department, Helsinki, Not set

Many Locations, Multiple Locations, Not set

Tays Service Centre | Tampere University Hospital - Pediatric Early Phase Clinical Trials Unit, Tampere, Not set

Turun yliopistollinen keskussairaala, Turku, Not set

CHU bordeaux - Hopital Pellegrin, BORDEAUX cedex, Not set

CHU de Lyon - Hopital Femme Mère Enfant, Bron, Not set

Hopital Arnaud de Villeneuve CHU Montpellier, Montpellier, Not set

Many Locations, Multiple Locations, Not set

Hopital Robert Debre, Paris, Not set

CHU Strasbourg - Hopital Hautepierre, Strasbourg, Not set

Hôpital des Enfants, TOULOUSE Cedex 9, Not set

Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg

Universitätsklinikum Erlangen, Erlangen, Bayern

Medizinische Hochschule Hannover (MHH) | Zentrum Innere Medizin | Klinik fuer Kardiologie und Angiologie, Hannover, Niedersachsen

Kindernierenzentrum Bonn, Bonn, Nordrhein-Westfalen

Universitätsklinikum Essen, Essen, Nordrhein-Westfalen

Universitaetsklinikum Muenster, Münster, Nordrhein-Westfalen

Charité / Pädiatrie, Berlin, Not set

Universitätsklinikum Hamburg Eppendorf (UKE), Hamburg, Not set

Many Locations, Multiple Locations, Not set

Children's Hospital of Athens P&A Kyriakou - Pediatric Nephrology Department, Athens, Not set

Children's Hospital of Athens Agia Sofia - Pediatric Nephrology Department, Athens, Not set

University General Hospital of Heraklion - Department of Paediatrics, Heraklion, Not set

Univ. General Hospital of Ioannina - Department of Paediatrics, Nephrology Unit, Ioannina, Not set

Many Locations, Multiple Locations, Not set

Hippokration General Hospital of Thessaloniki - 3rd Department of Paediatrics, Nephrology Unit', Thessaloniki, Not set

Semmelweis University, Budapest, Not set

Debreceni Egyetem Klinikai Kozpont, Debrecen, Not set

Many Locations, Multiple Locations, Not set

Pecsi Tudomanyegyetem Klinikai Kozpont, Pecs, Not set

SZTE ÁOK Szent Györgyi Albert Klinikai Kozpont, Szeged, Not set

All India Institute of Medical Sciences (AIIMS) - New Delhi, Delhi, Not set

NRS Medical college, Kolkata, Not set

Clalit Health | Soroka Medical Center - Internal Medicine Department, Beer Sheva, Not set

Wilf Children's Hospital Shaare Zedek Medical Center, Jerusalem, Not set

Many Locations, Multiple Locations, Not set

Health Corporation of Galilee Medical Center, Nahariya, Not set

Clalit Health Services Schneider Children's Medical Center, Petach Tikva, Not set

Dana-Dwek Children's Hospital, Tel Aviv, Not set

Azienda Ospedaliero-Universitaria Di Bologna IRCCS_Policlinico Sant'Orsola - Pediatria, Bologna, Emilia-Romagna

Ospedale Pediatrico Bambino Gesù - Nefrologia, Roma, Lazio

IRCCS Istituto Giannina Gaslini - Nefrologia e Trapianto Rene, Genova, Liguria

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Nefrologia e Dialisi Pediatrica, Trapianti di Rene, Milano, Lombardia

Azienda Ospedaliera Universitaria Meyer IRCCS - Nefrologia e Dialisi, Firenze, Not set

Many Locations, Multiple Locations, Not set

A.O.U. Città della Salute e della Scienza di Torino_Regina Margherita - Nefrologia Pediatrica, Torino, Not set

Kyungpook National University Hospital, Daegu, Daegu Gwang''yeogsi

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggido

Pusan National University Yangsan Hospital, Yangsan-si, Gyeongsangnamdo

Seoul National University Hospital, Seoul, Seoul Teugbyeolsi

Many Locations, Multiple Locations, Not set

Korea University Guro Hospital, Seoul, Not set

Hospital of LT University of Health Sciences Kaunas Clinics, Kaunas, Not set

Klaipeda Children's Hospital, Klaipeda, Not set

Many Locations, Multiple Locations, Not set

Vilnius University Hospital Santaros Klinikos Children's Hospital Paediatrics Centre, Vilnius, Not set

Hospital Tuanku Ja'afar, Seremban, Negeri Sembilan

Sitio Alfredo Chew Wong | Aguascalientes, Mexico, Aguascalientes, Agguascalientes

Hospital Infantil de México "Dr. Federico Gómez", México D.F., Distrito Federal

Instituto Nacional de Pediatría, México, D.F., Distrito Federal

Hospital Universitario "José Eleuterio González", Monterrey, Nuevo Leon

Instituto Veracruzano en Investigación Clinica SC, Veracruz, Not set

Universitair Medisch Centrum Groningen, Groningen, Not set

Many Locations, Multiple Locations, Not set

University Medical Center Utrecht, Utrecht, Not set

Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa, Bialystok, Not set

Uniwersyteckie Centrum Kliniczne, Gdansk, Not set

Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow, Not set

Instytut Centrum Zdrowia Matki Polki, Lodz, Not set

Many Locations, Multiple Locations, Not set

Instytut "Pomnik - Centrum Zdrowia Dziecka", Warszawa, Not set

Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego We Wroclawiu, Wroclaw, Not set

Hospital Santa Maria | Centro de Investigacao Clinica, Missing, Lisboa

Centro Clinico Academico Braga | Braga, Portugal, Braga, Not set

Hospital Pediátrico de Coimbra I ULS Coimbra, Coimbra, Not set

Centro Hospitalar Universitario do Porto | Servico de Investigacao Clinica, Porto, Not set

Ciutat Sanitaria i Universitaria de la Vall d'Hebron, Barcelona, Not set

Hospital de Sant Joan de Déu, Barcelona, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital la Paz, Madrid, Not set

Many Locations, Multiple Locations, Not set

Hospital Universitario Regional De Malaga - Nefrologia pediatrica, Málaga, Not set

Hospital Universitario Virgen Del Rocio S.L. - Nefrologia pediatrica, Sevilla, Not set

Skåne University Hospital, Lund, Not set

Many Locations, Multiple Locations, Not set

Karolinska University Hospital, Stockholm, Not set

Uppsala University Hospital, Uppsala, Not set

Universitäts-Kinderspital UKBB, Basel, Basel-Stadt

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Vaud

Hopital des Enfants HUG, Geneva, Not set

Many Locations, Multiple Locations, Not set

Hacettepe Universitesi Tip Fakultesi, Ankara, Not set

Baskent Universitesi Tip Fakultesi Hastanesi, Ankara, Not set

Gazi Universitesi Tip Fakultesi, Ankara, Not set

Health Ministry Of Türkiye Republic Ankara Bilkent City Hospital, Ankara, Not set

Istanbul Faculty of Medicine, Department of Internal Medicine, Department of Pediatrics, Istanbul, Not set

Istanbul Universitesi Cerrahpasa - Cocuk Nefrolojisi, Istanbul, Not set

Marmara University Medical Faculty | Pediatric Nephrology, Istanbul, Not set

Many Locations, Multiple Locations, Not set

NHS Greater Glasgow and Clyde | Royal Hospital for Children - Glasgow Clinical Research Facility, Glasgow, Stratchclyde

Birmingham Children's Hospital, Birmingham, West Midlands

Great Ormond Street Hospital for Children, London, Not set

Manchester University NHS Foundation Trust | Royal Manchester Children's Hospital - Clinical Research Facility, Manchester, Not set

Many Locations, Multiple Locations, Not set

Nottingham University Hospitals NHS Trust | Queens Medical Centre - Childrens Clinical Research Facility, Nottingham, Not set

Conditions: Chronic Kidney Disease, Proteinuria, Children

Learn More ›

Post-operative Changes Study

NCT07121660

Recruiting

The goal of this observational pilot study is to evaluate the feasibility and acceptability of the protocol to explore the functional post-operative trajectory in a developmentally and neurologically impaired pediatric population. The main objectives of the study are: * Objective 1: To evaluate the feasibility and acceptability of the study protocol for children and families living with severe neurological impairment (SNI). To evaluate feasibility the investigators will assess consent rate, pr... Read More

Gender:

ALL

Ages:

Between 5 years and 18 years

Trial Updated:

08/06/2025

Locations: BC Children's Hospital Research Institute, Vancouver, British Columbia

Conditions: Post-operative Functional Decline, Severe Neurological Impairment

Learn More ›

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

NCT06534892

Recruiting

The purpose of this study is: * To investigate the optimal timing for revaccination after the initial RSVPreF3 OA vaccine dose, * To evaluate the long-term immune persistence and safety up to 5 consecutive RSV seasons (approximately 60 months) of a single dose of RSVPreF3 OA vaccine, * To give the opportunity to participants who received only placebo in the RSVOA=ADJ- 006 study, to receive a dose of the RSVPreF3 OA vaccine and collect additional safety information.

Gender:

ALL

Ages:

60 years and above

Trial Updated:

08/06/2025

Locations: GSK Investigational Site, Birmingham, Alabama +251 locations

GSK Investigational Site, Birmingham, Alabama

GSK Investigational Site, Huntsville, Alabama

GSK Investigational Site, Phoenix, Arizona

GSK Investigational Site, Tucson, Arizona

GSK Investigational Site, Cerritos, California

GSK Investigational Site, Coral Gables, Florida

GSK Investigational Site, Fort Myers, Florida

GSK Investigational Site, Jacksonville, Florida

GSK Investigational Site, Lake City, Florida

GSK Investigational Site, Melbourne, Florida

GSK Investigational Site, Miami, Florida

GSK Investigational Site, Orlando, Florida

GSK Investigational Site, Pinellas Park, Florida

GSK Investigational Site, The Villages, Florida

GSK Investigational Site, West Palm Beach, Florida

GSK Investigational Site, Atlanta, Georgia

GSK Investigational Site, Savannah, Georgia

GSK Investigational Site, Chicago, Illinois

GSK Investigational Site, Evansville, Indiana

GSK Investigational Site, Mishawaka, Indiana

GSK Investigational Site, El Dorado, Kansas

GSK Investigational Site, Newton, Kansas

GSK Investigational Site, Wichita, Kansas

GSK Investigational Site, Lexington, Kentucky

GSK Investigational Site, Rockville, Maryland

GSK Investigational Site, Richfield, Minnesota

GSK Investigational Site, Kansas City, Missouri

GSK Investigational Site, Saint Louis, Missouri

GSK Investigational Site, Omaha, Nebraska

GSK Investigational Site, Las Vegas, Nevada

GSK Investigational Site, New York, New York

GSK Investigational Site, Rochester, New York

GSK Investigational Site, Hickory, North Carolina

GSK Investigational Site, Mooresville, North Carolina

GSK Investigational Site, Rocky Mount, North Carolina

GSK Investigational Site, Salisbury, North Carolina

GSK Investigational Site, Winston-Salem, North Carolina

GSK Investigational Site, Centerville, Ohio

GSK Investigational Site, Cincinnati, Ohio

GSK Investigational Site, Columbus, Ohio

GSK Investigational Site, Erie, Pennsylvania

GSK Investigational Site, Pittsburgh, Pennsylvania

GSK Investigational Site, Anderson, South Carolina

GSK Investigational Site, Mount Pleasant, South Carolina

GSK Investigational Site, Knoxville, Tennessee

GSK Investigational Site, Memphis, Tennessee

GSK Investigational Site, Dallas, Texas

GSK Investigational Site, Fort Worth, Texas

GSK Investigational Site, Houston, Texas

GSK Investigational Site, Keller, Texas

GSK Investigational Site, San Antonio, Texas

GSK Investigational Site, Salt Lake City, Utah

GSK Investigational Site, Norfolk, Virginia

GSK Investigational Site, Botany, New South Wales

GSK Investigational Site, Coffs Harbour, New South Wales

GSK Investigational Site, Darlinghurst, New South Wales

GSK Investigational Site, Taringa, Queensland

GSK Investigational Site, Tarragindi, Queensland

GSK Investigational Site, Camberwell, Victoria

GSK Investigational Site, Geelong, Victoria

GSK Investigational Site, Spearwood, Western Australia

GSK Investigational Site, Diepenbeek, Not set

GSK Investigational Site, Edegem, Not set

GSK Investigational Site, Erpent, Not set

GSK Investigational Site, Genk, Not set

GSK Investigational Site, Gent, Not set

GSK Investigational Site, Ieper, Not set

GSK Investigational Site, Kluisbergen, Not set

GSK Investigational Site, Linkebeek, Not set

GSK Investigational Site, Mechelen, Not set

GSK Investigational Site, Tremelo, Not set

GSK Investigational Site, Edmonton, Alberta

GSK Investigational Site, New Westminster, British Columbia

GSK Investigational Site, Surrey, British Columbia

GSK Investigational Site, Vancouver, British Columbia

GSK Investigational Site, Victoria, British Columbia

GSK Investigational Site, Halifax, Nova Scotia

GSK Investigational Site, Truro, Nova Scotia

GSK Investigational Site, London-Ontario, Ontario

GSK Investigational Site, Ottawa, Ontario

GSK Investigational Site, Sarnia, Ontario

GSK Investigational Site, Sudbury, Ontario

GSK Investigational Site, Toronto, Ontario

GSK Investigational Site, Chicoutimi, Quebec

GSK Investigational Site, Mirabel, Quebec

GSK Investigational Site, Pointe-Claire, Quebec

GSK Investigational Site, Sainte-Foy, Quebec

GSK Investigational Site, Sherbrooke, Quebec

GSK Investigational Site, St-Charles-Borromee, Quebec

GSK Investigational Site, Quebec, Not set

GSK Investigational Site, Paide, Not set

GSK Investigational Site, Tallinn, Not set

GSK Investigational Site, Tartu, Not set

GSK Investigational Site, Espoo, Not set

GSK Investigational Site, Helsinki, Not set

GSK Investigational Site, Jarvenpaa, Not set

GSK Investigational Site, Kokkola, Not set

GSK Investigational Site, Oulu, Not set

GSK Investigational Site, Seinajoki, Not set

GSK Investigational Site, Tampere, Not set

GSK Investigational Site, Turku, Not set

GSK Investigational Site, Weinheim, Baden-Wuerttemberg

GSK Investigational Site, Muenchen, Bayern

GSK Investigational Site, Freiberg, Sachsen

GSK Investigational Site, Berlin, Not set

GSK Investigational Site, Dachau, Not set

GSK Investigational Site, Dippoldiswalde, Not set

GSK Investigational Site, Dresden, Not set

GSK Investigational Site, Essen, Not set

GSK Investigational Site, Frankfurt, Not set

GSK Investigational Site, Freital, Not set

GSK Investigational Site, Goch, Not set

GSK Investigational Site, Hamburg, Not set

GSK Investigational Site, Hannover, Not set

GSK Investigational Site, Hochheim am Main, Not set

GSK Investigational Site, Koeln, Not set

GSK Investigational Site, Leipzig, Not set

GSK Investigational Site, Mainz, Not set

GSK Investigational Site, Schenefeld, Not set

GSK Investigational Site, Wallerfing, Not set

GSK Investigational Site, Wangen, Not set

GSK Investigational Site, Witten, Not set

GSK Investigational Site, Wuerzburg, Not set

GSK Investigational Site, Alessandria, Not set

GSK Investigational Site, Bari, Not set

GSK Investigational Site, Belluno, Not set

GSK Investigational Site, Ferrara, Not set

GSK Investigational Site, Napoli, Not set

GSK Investigational Site, Negrar Verona, Not set

GSK Investigational Site, Palermo, Not set

GSK Investigational Site, Pessione - Chieri TO, Not set

GSK Investigational Site, Pisa, Not set

GSK Investigational Site, Roma, Not set

GSK Investigational Site, Siena, Not set

GSK Investigational Site, Hiroshima, Not set

GSK Investigational Site, Ibaraki, Not set

GSK Investigational Site, Kumamoto, Not set

GSK Investigational Site, Okinawa, Not set

GSK Investigational Site, Saitama, Not set

GSK Investigational Site, Shizuoka, Not set

GSK Investigational Site, Tokyo, Not set

GSK Investigational Site, Yamagata, Not set

GSK Investigational Site, Yamaguchi, Not set

GSK Investigational Site, Ansan, Not set

GSK Investigational Site, Bucheon-si Kyunggi-do 14584, Not set

GSK Investigational Site, Daegu, Not set

GSK Investigational Site, Incheon, Not set

GSK Investigational Site, Jeonju, Not set

GSK Investigational Site, Kangwon-do, Not set

GSK Investigational Site, Seoul, Not set

GSK Investigational Site, Suwon Gyeonggi-do, Not set

GSK Investigational Site, Chihuahua, Not set

GSK Investigational Site, Leon, Not set

GSK Investigational Site, Merida, Not set

GSK Investigational Site, Mexico City, Not set

GSK Investigational Site, Monterrey, Not set

GSK Investigational Site, Oaxaca, Not set

GSK Investigational Site, Queretaro, Not set

GSK Investigational Site, RM Pharmamexico CITY, Not set

GSK Investigational Site, San Luis PotosI, Not set

GSK Investigational Site, Grafton Auckland, Not set

GSK Investigational Site, Hawke's Bay, Not set

GSK Investigational Site, Kapiti, Not set

GSK Investigational Site, Palmerston North, Not set

GSK Investigational Site, Tauranga, Not set

GSK Investigational Site, Wellington, Not set

GSK Investigational Site, Czestochowa, Not set

GSK Investigational Site, Elblag, Not set

GSK Investigational Site, Gdansk, Not set

GSK Investigational Site, Gdynia, Not set

GSK Investigational Site, Katowice, Not set

GSK Investigational Site, Krakow, Not set

GSK Investigational Site, Lodz, Not set

GSK Investigational Site, Poznan, Not set

GSK Investigational Site, Warsaw, Not set

GSK Investigational Site, Warszawa, Not set

GSK Investigational Site, Wroclaw, Not set

GSK Investigational Site, Gatchina, Leningrad Region

GSK Investigational Site, Barnaul, Not set

GSK Investigational Site, Ekaterinburg, Not set

GSK Investigational Site, Kemerovo, Not set

GSK Investigational Site, Moscow, Not set

GSK Investigational Site, Saint-Petersburg, Not set

GSK Investigational Site, StPetersburg, Not set

GSK Investigational Site, Bloemfontein, Not set

GSK Investigational Site, Cape Town, Not set

GSK Investigational Site, Johannesburg, Not set

GSK Investigational Site, Middelburg, Not set

GSK Investigational Site, Moloto South, Not set

GSK Investigational Site, Reiger Park, Not set

GSK Investigational Site, Tembisa, Not set

GSK Investigational Site, AlcorcOn, Not set

GSK Investigational Site, Barcelona, Not set

GSK Investigational Site, Madrid, Not set

GSK Investigational Site, Santiago de Compostela, Not set

GSK Investigational Site, Valencia, Not set

GSK Investigational Site, Bebington, Not set

GSK Investigational Site, Belfast, Not set

GSK Investigational Site, Birmingham, Not set

GSK Investigational Site, Bradford On Avon Wiltsh, Not set

GSK Investigational Site, Cardiff, Not set

GSK Investigational Site, Corby, Not set

GSK Investigational Site, Eynsham, Not set

GSK Investigational Site, Glasgow, Not set

GSK Investigational Site, Hexham, Not set

GSK Investigational Site, Lancashire, Not set

GSK Investigational Site, Leamington Spa, Not set

GSK Investigational Site, Liverpool, Not set

GSK Investigational Site, Manchester, Not set

GSK Investigational Site, Orpington, Not set

GSK Investigational Site, Oxford, Not set

GSK Investigational Site, Peterborough, Not set

GSK Investigational Site, Thetford, Not set

GSK Investigational Site, Witney, Not set

Conditions: Respiratory Syncytial Virus Infections

Learn More ›

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

NCT05531565

Recruiting

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with cutaneous lupus erythematosus (CLE). The study will focus on participants who have either active subacute CLE or chronic CLE, or both. They may also have systemic lupus erythematosus (SLE). The participants did not respond to antimalarial therapy or had problems with the treatment that made it hard to continue. The main objective of the study is to learn about the effect litifilimab has on lowering the activity of the skin disease. Researchers will measure symptoms of CLE over time using a variety of scoring tools. These include the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI), the Cutaneous Lupus Activity of Investigator's Global Assessment-Revised (CLA-IGA-R), and the SELENA-SLEDAI Flare Index (SFI). The main questions researchers want to answer are: * How many participants have a score of 0 or 1 on the CLA-IGA-R looking at skin redness after treatment? * How many participants have their skin disease activity go down by at least 70%? Researchers will also learn more about the safety of litifilimab. They will study how participants' immune systems respond to litifilimab. Additionally, they will measure the effect litifilimab and CLE have on the quality of life of participants using a group of questionnaires. The study will be split into 2 parts - Part A and Part B. Both parts will be done as follows: * After screening, participants will be randomized to receive either litifilimab or placebo for the 1st treatment period. A placebo looks like the study drug but contains no real medicine. * Participants will receive either litifilimab or placebo as injections under the skin once every 4 weeks. * The 1st treatment period will be double blinded which means neither the researchers nor the participants will know if the participants are receiving litifilimab or placebo. * This double blinded treatment period will last 24 weeks, after which the 2nd treatment period will begin. * During the 2nd treatment period, all participants will receive litifilimab for 28 weeks. * After completing treatment in this study, participants that qualify will be given the choice to join the Long-Term Extension study, 230LE305. If they do not, they will move into a follow-up safety period that will last up to 24 weeks. * The total study duration for participants will be up to 80 weeks Read Less

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/06/2025

Locations: Pinnacle Research Group, LLC, Anniston, Alabama +257 locations

Pinnacle Research Group, LLC, Anniston, Alabama

UAB Center for Women's Reproductive Health, Birmingham, Alabama

Arizona Arthritis & Rheumatology Research, PLLC, Phoenix, Arizona

The Regents of the University of California, La Jolla, California

Dermatology Research Associates, Los Angeles, California

Clinical Science Institute, Santa Monica, California

Inland Rheumatology Clinical Trials, Inc., Upland, California

Denver Arthritis Clinic, Denver, Colorado

Omega Research Debary, LLC, DeBary, Florida

Centre for Rheumatology, Immunology and Arthritis, Fort Lauderdale, Florida

University of Florida, Gainesville, Florida

Charisma Medical and Research Center, Miami Lakes, Florida

University of Miami Miller School of Medicine, Miami, Florida

Medical Research Center of Miami, Miami, Florida

Augusta University, Augusta, Georgia

Rush University Medical Center, Chicago, Illinois

OrthoIllinois, Rockford, Illinois

Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana

LSU Health Sciences Center Shreveport, New Orleans, Louisiana

Tufts Medical Center, Boston, Massachusetts

Brigham And Women's Hospital, Boston, Massachusetts

Essential Dermatology, Natick, Massachusetts

Beacon Clinical Research, LLC, Quincy, Massachusetts

University of Massachusetts, Worcester, Worcester, Massachusetts

David Fivenson, MD, Dermatology, PLLC, Ann Arbor, Michigan

Oakland Hills Dermatology, Auburn Hills, Michigan

AA MRC LLC Ahmed Arif Medical Research Center, Flint, Michigan

Revival Research Institute, LLC, Troy, Michigan

Saint Louis University, Saint Louis, Missouri

University of Nebraska Medical Center, Omaha, Nebraska

Albuquerque Center For Rheumatology, Albuquerque, New Mexico

University of New Mexico School of Medicine, Albuquerque, New Mexico

NYU Langone Brooklyn, Brooklyn, New York

Universal Dermatology, PLLC, Fairport, New York

Northwell Health, Inc. PRIME, Great Neck, New York

Columbia University Medical center, New York, New York

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Duke Dermatology South Durham, Durham, North Carolina

Medication Management, LLC, Greensboro, North Carolina

University of Cincinnati Department of Dermatology, Cincinnati, Ohio

University Hospitals Cleveland Medical Center, Cleveland, Ohio

Ohio State University, Columbus, Ohio

Penn State University Milton S. Hershey Medical Center, Hershey, Pennsylvania

University of Pennsylvania, Philadelphia, Pennsylvania

Vanderbilt University Medical Center, Nashville, Tennessee

Austin Regional Clinic, P.A., Austin, Texas

Precision Comprehensive Clinical Research Solutions, Colleyville, Texas

Metroplex Clinical Research Center, LLC, Dallas, Texas

UT Southwestern Medical Center, Dallas, Texas

North Texas Center for Clinical Research, Frisco, Texas

UTMB Department of Dermatology, Galveston, Texas

University of Texas Health Science Center at Houston, Houston, Texas

Arthritis & Osteoporosis Clinic, Waco, Texas

University of Utah Health Sciences Center, Salt Lake City, Utah

West End Dermatology Associates, Richmond, Virginia

CINME - Centro De Investigaciones Metabolicas, Caba, Buenos Aires

Centro de Investigaciones Medicas Mar del Plata, Mar del Plata, Buenos Aires

Instituto de Investigaciones Clinicas Quilmes, Quilmes, Buenos Aires

APRILLUS Asistencia e Investigacion, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma Buenos Aires

Fundacion Respirar, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma Buenos Aires

Instituto CAICI, Rosario, Santa Fe

Clinica Mayo de Urgencias Medicas Cruz Blanca SRL, San Miguel de Tucuman, Tucuman

Centro de Investigaciones Medicas Tucuman, San Miguel de Tucuman, Tucuman

Investigaciones Clinicas Tucuman, San Miguel de Tucuman, Tucuman

Hospital Italiano de La Plata, Buenos Aires, Not set

Centro Privado de Medicina Familiar - Mind Out Research, Ciudad Autonoma Buenos Aires, Not set

Clinica Adventista Belgrano, Ciudad Autonoma Buenos Aires, Not set

Instituto de Reumatologia, Mendoza, Not set

CER San Juan Centro Polivalente de Asistencia e Inv. Clinica, San Juan, Not set

Clínica SER da Bahia, Salvador, Bahia

HUWC - UFC - Hospital Universitário Walter Cantídio - Universidade Federal do Ceará, Fortaleza, Ceará

L2IP - Instituto de Pesquisas Clínicas Ltda., Brasilia, Distrito Federal

CEDOES - Diagnóstico e Pesquisa, Vitória, Espírito Santo

IPC MT Instituto de Pesquisas Clinicas do Mato Grosso, Santo Ângelo, Mato Grosso

Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, Minas Gerais

CMiP - Centro Mineiro de Pesquisa, Juiz de Fora, Minas Gerais

Instituto Brasil de Pesquisa Clínica-IBPCLIN S/A, Rio de Janeiro, Rio Do Janeiro

IDERJ - Instituto de Dermatologia e Estética do Brasil Ltda, Rio de Janeiro, Rio Do Janeiro

Hospital Bruno Born, Lajeado, Rio Grande Do Sul

Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul

Nucleo de Pesquisa Clinica do Rio Grande do Sul, Porto Alegre, Rio Grande Do Sul

LMK Serviços Médicos S/S Ltda, Porto Alegre, Rio Grande Do Sul

CEMEC - Centro Multidisciplinar de Estudos Clínicos, Sao Bernardo Do Campo, Sao Paulo

CEPIC - Centro Paulista de Investigação Clínica e Serviços Médicos, São Paulo, Sao Paulo

Medical center Medconsult Pleven OOD, Pleven, Not set

UMHAT 'Dr. Georgi Stranski', EAD, Pleven, Not set

DCC 1 - Ruse, EOOD, Ruse, Not set

DCC 'Alexandrovska', EOOD, Sofia, Not set

DCC Focus 5 - MEOH OOD, Sofia, Not set

Military Medical Academy - MHAT - Sofia, Sofia, Not set

Laser Rejuvenation Clinics, Inc., Calgary, Alberta

Laster Rejuvenation Clinics Edmonton D.T. Inc., Edmonton, Alberta

Dermatology Ottawa Research Centre, Ottawa, Ontario

Medicor Research Inc, Sudbury, Ontario

DIEX Recherche Sherbrooke Inc., Sherbrooke, Quebec

Centro Medico SkinMed, Las Condes, Not set

Dermacross, Santiago, Not set

BioMedica Research Group, Santiago, Not set

CeCim Biocinetic, Santiago, Not set

CIEC - Centro Internacional de Estudios Clínicos, Santiago, Not set

Clinical Research Chile SpA., Valdivia, Not set

Oncocentro APYS, Viña del Mar, Not set

Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing

Peking Union Medical College Hospital, Beijing, Beijing

The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing

The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian

Dongguan People's Hospital, Dongguan, Guangdong

Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong

Shenzhen Second People's Hospital, Shenzhen, Guangdong

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangzhou

Nanyang First People's Hospital, Nanyang, Henan

Henan Provincial People's Hospital, Zhengzhou, Henan

The second Xiangya Hospital of Central South University, Changsha, Hunan

The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia

Hospital for Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, Jiangsu

Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu

The First Hospital of Jilin University, Changchun City, Jilin

Qilu Hospital of Shandong University, Jinan, Shandong

Ruijin Hospital of Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai

Zhongshan Hospital Fudan University, Shanghai, Shanghai

Shanghai Skin Disease Hospital, Shanghai, Shanghai

The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan

The First Affiliated Hospital of Zhejiang University school of medicine, Hangzhou, Zhejiang

Hangzhou First People's Hospital, Hangzhou, Zhejiang

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang

Centro de Investigacion Medico Asistencial S.A.S, Barranquilla, Atlántico

Healthy Medical Center, Zipaquirá, Cundinamarca

Servimed S.A.S., Bucaramanga, Santander

Centro de Investigacion en Reumatologia y Especialidades Medicas SAS. CIREEM, Bogotá, Not set

CHU Nice - Hopital de l Archet, Nice cedex 3, Alpes Maritimes

Hôpital de la Timone, Marseille cedex 5, Bouches-du-Rhône

CHU de Caen - Hopital de la Cote de Nacre, Caen, Calvados

CHU Besançon - Hôpital Jean Minjoz, Besançon Cedex, Doubs

Hopital Larrey, Toulouse Cedex 9, Haute Garonne

Hôpital Privé d'Antony, Antony, Hauts De Seine

Hopital Saint Eloi, Montpellier Cedex 5, Herault

Hôpital Saint-Louis, Cedex 10, Paris

Hopital Edouard Herriot - CHU Lyon, Lyon, Rhone

Hopital Tenon, Paris, Not set

Universitaetsklinikum Heidelberg, Heidelberg, Baden Wuerttemberg

Universitaetsklinikum Erlangen, Erlangen, Bayern

Fachklinik Bad Bentheim Dermatologie, Bad Bentheim, Niedersachsen

Elbekliniken Buxtehude GmbH, Buxtehude, Niedersachsen

Klinikum Oldenburg AoeR, Oldenburg, Niedersachsen

Universitaetsklinikum Aachen AoeR, Aachen, Nordrhein Westfalen

Universitaetsklinikum Bonn AoeR, Bonn, Nordrhein Westfalen

Universitaetsklinikum Duesseldorf AoeR, Duesseldorf, Nordrhein Westfalen

Universitaetsklinikum Muenster, Muenster, Nordrhein Westfalen

Universitaetsklinikum Halle (Saale), Halle, Sachsen Anhalt

Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden, Sachsen

Universitaetsklinikum Schleswig-Holstein - Campus Kiel, Kiel, Schleswig Holstein

Charité - Campus Charité Mitte, Berlin, Not set

Pecsi Tudomanyegyetem, Pecs, Not set

Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS, Bologna, Not set

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili), Brescia, Not set

Università degli studi di Firenze, Firenze, Not set

IRCCS Ospedale Policlinico San Martino, Genova, Not set

Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milano, Not set

Ospedale San Raffaele, Milano, Not set

Azienda Ospedaliera Universitaria Policlinico 'Federico II', Napoli, Not set

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Not set

JCHO Chukyo Hospital, Nagoya-shi, Aichi-Ken

NHO Nagoya Medical Center, Nagoya-shi, Aichi-Ken

Fujita Health University Hospital, Toyoake-shi, Aichi-Ken

Aomori Prefectural Central Hospital, Aomori-shi, Aomori-Ken

Juntendo University Urayasu Hospital, Urayasu-shi, Chiba-Ken

University of Fukui Hospital, Yoshida-gun, Fukui-Ken

Hospital of the University of Occupational and Environmental Health, Kitakyushu-shi, Fukuoka-Ken

Hokkaido University Hospital, Sapporo-shi, Hokkaido

Kakogawa Central City Hospital, Kakogawa-shi, Hyogo-Ken

Kita Harima Medical Center, Ono-shi, Hyogo-Ken

Kanazawa University Hospital, Kanazawa-shi, Ishikawa-Ken

St. Marianna University Hospital, Kawasaki-shi, Kanagawa-Ken

Yokohama City University Medical Center, Yokohama-shi, Kanagawa-Ken

Yokohama City University Hospital, Yokohama-shi, Kanagawa-Ken

NHO Yokohama Medical Center, Yokohama-shi, Kanagawa-Ken

Kumamoto University Hospital, Kumamoto-shi, Kumamoto-Ken

Tohoku University Hospital, Sendai-shi, Miyagi-Ken

Nagasaki University Hospital, Nagasaki-Shi, Nagasaki-Ken

Niigata University Medical & Dental Hospital, Niigata-shi, Niigata-Ken

Japanese Red Cross Okayama Hospital, Okayama-shi, Okayama-Ken

NHO Osaka Minami Medical Center, Kawachinagano-shi, Osaka-Fu

Daini Osaka Police Hospital, Osaka-shi, Osaka-Fu

Kindai University Hospital, Osakasayama-shi, Osaka-Fu

Osaka University Hospital, Suita-shi, Osaka-Fu

Takatsuki Red Cross Hospital, Takatsuki-shi, Osaka-Fu

Shiga University of Medical Science Hospital, Otsu-shi, Shiga-Ken

Shimane University Hospital, Izumo-shi, Shimane-Ken

Teikyo University Hospital, Itabashi-ku, Tokyo-To

Showa University East Hospital, Shinagawa-ku, Tokyo-To

Wakayama Medical University Hospital, Wakayama-shi, Wakayama-Ken

Korea University Ansan Hospital, Ansan-si, Gyeonggi-do

Ajou University Hospital, Suwon, Gyeonggi-do

Chonnam National University Hospital, Gwangju, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

Hanyang University Seoul Hospital, Seoul, Not set

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Not set

Clinstile, S.A. de C.V., Ciudad de México, Distrito Federal

Centro de Investigacion Clínica GRAMEL S.C, Mexico, Distrito Federal

Centro de investigacion medica y reumatologia, Guadalajara, Jalisco

Consultorio Privado Dr. Miguel Cortes Hernandez, Cuernavaca, Morelos

Medical Care & Research SA de CV, Merida, Yucatán

Derma Norte del Bajio S.C., Aguascalientes, Not set

Investigacion y Biomedicina de Chihuahua, S.C., Chihuahua, Not set

Invest Clinicas Sac Inst de Ginecologia y Reproduccion, Lima, Not set

The Medical City Clark, Mabalacat, Pampanga

Cebu Doctors University Hospital, Cebu City, Not set

Mary Mediatrix Medical Center, Lipa City, Not set

Medical Center Manila, Manila, Not set

Philippine General Hospital, Manila, Not set

Jose R. Reyes Memorial Medical Center, Manila, Not set

Far Eastern University - Dr. Nicanor Reyes Medical Foundation, Quezon City, Metro Manila, Not set

St. Luke's Medical Center, Quezon City, Not set

Ilocos Training and Regional Medical Center, San Fenando, La Union, Not set

Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy Marek Brzewski, Krakow, Not set

SPZOZ Szpital Uniwersytecki w Krakowie, Kraków, Not set

Dermoklinika Centrum Medyczne SC M Kierstan J Narbutt A Lesiak, Lodz, Not set

Kliniczny Szpital Wojewodzki nr 1 im.F.Chopina, Rzeszow, Not set

Szpital Kliniczny Dzieciatka Jezus, Warszawa, Not set

Royalderm, Warszawa, Not set

Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spółka Partnerska, Wroclaw, Not set

Centro Hospitalar e Universitário de Coimbra, E.P.E (HUC), Coimbra, Not set

Hospital de Egas Moniz, Lisboa, Not set

Hospital CUF Descobertas, Lisboa, Not set

Centro Hospitalar Universitártio do Porto, E.P.E., Porto, Not set

Unidade Local de Saúde do Alto Minho, E.P.E., Viana do Castelo, Not set

Dr. Samuel Sanchez PSC, Caguas, Not set

GCM Medical Group PSC - Hato Rey, San Juan, Not set

King Faisal Specialist Hospital & Research Center, Riyadh, Not set

King Saud University, Riyadh, Not set

Institute of Rheumatology, Belgrade, Not set

University Clinical Center of Serbia, Belgrade, Not set

University Clinical Center Kragujevac, Kragujevac, Not set

Clinical Center of Vojvodina, Novi Sad, Not set

Artromac n.o., Kosice, Not set

Narodny ustav reumatickych chorob, Piestany, Not set

Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona

Hospital Universitario Rio Hortega, Valladolid, Cantabria

Hospital Universitario Fundacion Alcorcon, Alcorcón, Madrid

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid

Hospital del Mar, Barcelona, Not set

Hospital de la Santa Creu i Sant Pau, Barcelona, Not set

Hospital Universitario Reina Sofia, Cordoba, Not set

Complejo Hospitalario Universitario A Coruña, La Coruña, Not set

Hospital Universitario Virgen del Rocio, Sevilla, Not set

Karolinska Universitetssjukhuset - Solna, Stockholm, Not set

Universitaetsspital Zuerich, Zurich-Flughafen, Zurich

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Not set

Kantonsspital St. Gallen, St. Gallen, Not set

Changhua Christian Medical Foundation Changhua Christian Hospital, Changhua, Not set

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Not set

Taichung Veterans General Hospital, Taichung, Not set

Taipei Veterans General Hospital, Taipei, Not set

Whipps Cross University Hospital, London, Greater London

Manchester Royal Infirmary, Manchester, Greater Manchester

Queen Elizabeth Hospital, Birmingham, West Midlands

Chapel Allerton Hospital, Leeds, West Yorkshire

Conditions: Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus

Learn More ›

A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease

NCT06734234

Recruiting

This is a study where a new drug, called GSK4771261 is being tested. Neither the study doctors, study staff or participants will be aware of what treatment is being given. Part A is testing the new study treatment on healthy people. This is to see if it's safe, what it does to the body, and how the body's defense system responds to it. Part B is similar, but the study treatment will be given to people who have a kidney disease called autosomal dominant polycystic kidney disease (ADPKD).

Gender:

ALL

Ages:

Between 25 years and 65 years

Trial Updated:

08/06/2025

Locations: GSK Investigational Site, Bruxelles, Not set +13 locations

Conditions: Kidney Disease

Learn More ›

A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada

NCT05424562

Recruiting

Acute Myeloid Leukemia (AML) is a cancer of the blood and bone marrow and is the most common acute leukemia in adults. This study will evaluate how well venetoclax works to treat AML in adult participants who are ineligible for intensive induction chemotherapy in Canada. Venetoclax is a drug approved to treat Acute Myeloid Leukemia (AML). All study participants will receive Venetoclax as prescribed by their study doctor in accordance with approved local label. Adult participants with a new diag... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/06/2025

Locations: Tom Baker Cancer Centre /ID# 248113, Calgary, Alberta +19 locations

Conditions: Acute Myeloid Leukemia

Learn More ›

Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma

NCT07112170

Recruiting

This open-label, prospective, single-arm Phase II trial explores whether adding stereotactic body radiotherapy (SBRT) or hypofractionated radiotherapy to oligoprogressive lesions can help delay disease progression in patients with metastatic melanoma. Participants may have up to ten extracranial oligoprogressive sites, with no upper limit on the total number of metastatic lesions. The study aims to assess whether targeting these progressing sites with focused radiotherapy can extend progression-... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/06/2025

Locations: University Health Network, Toronto, Ontario

Conditions: Metastatic Melanoma, OligoProgressive Metastatic Disease

Learn More ›

A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

NCT06544655

Recruiting

The purpose of this study is to assess the safety and tolerability of BMS-986484 administered alone, in combination with nivolumab in participants with advanced/metastatic solid tumors including non-small cell lung cancer (NSCLC), microsatellite stable (MSS) colorectal carcinoma (CRC), pancreatic ductal adenocarcinoma (PDAC), gastric/gastroesophageal junction adenocarcinoma (G/GEJC), and squamous cell carcinoma of the head and neck (SCCHN).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/06/2025

Locations: University of Arizona Cancer Center, Tucson, Arizona +8 locations

Conditions: Advanced Solid Tumors

Learn More ›

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

NCT06120491

Recruiting

The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA by assessment of radiographic progression-free survival (rPFS) in participants with mCSPC.

Gender:

MALE

Ages:

Between 18 years and 130 years

Trial Updated:

08/06/2025

Locations: Research Site, Chandler, Arizona +408 locations

Research Site, Chandler, Arizona

Research Site, Gilbert, Arizona

Research Site, Phoenix, Arizona

Research Site, Tucson, Arizona

Research Site, Little Rock, Arkansas

Research Site, Springdale, Arkansas

Research Site, Bakersfield, California

Research Site, Fountain Valley, California

Research Site, Fullerton, California

Research Site, Los Angeles, California

Research Site, Montebello, California

Research Site, Pasadena, California

Research Site, Pomona, California

Research Site, Sacramento, California

Research Site, San Diego, California

Research Site, San Francisco, California

Research Site, Santa Barbara, California

Research Site, Santa Monica, California

Research Site, Santa Rosa, California

Research Site, Golden, Colorado

Research Site, Lakewood, Colorado

Research Site, New Haven, Connecticut

Research Site, Norwich, Connecticut

Research Site, Newark, Delaware

Research Site, Jacksonville, Florida

Research Site, Palm Bay, Florida

Research Site, Saint Petersburg, Florida

Research Site, Tampa, Florida

Research Site, Atlanta, Georgia

Research Site, Glenview, Illinois

Research Site, Lake Barrington, Illinois

Research Site, Fort Wayne, Indiana

Research Site, Indianapolis, Indiana

Research Site, Des Moines, Iowa

Research Site, Westwood, Kansas

Research Site, Wichita, Kansas

Research Site, Lexington, Kentucky

Research Site, Louisville, Kentucky

Research Site, Shreveport, Louisiana

Research Site, Scarborough, Maine

Research Site, Baltimore, Maryland

Research Site, Bethesda, Maryland

Research Site, Towson, Maryland

Research Site, Upper Marlboro, Maryland

Research Site, Grand Rapids, Michigan

Research Site, Troy, Michigan

Research Site, Rochester, Minnesota

Research Site, Columbia, Missouri

Research Site, Billings, Montana

Research Site, Bozeman, Montana

Research Site, Las Vegas, Nevada

Research Site, Belleville, New Jersey

Research Site, Brick, New Jersey

Research Site, Camden, New Jersey

Research Site, East Brunswick, New Jersey

Research Site, Voorhees, New Jersey

Research Site, Albuquerque, New Mexico

Research Site, Rio Rancho, New Mexico

Research Site, Albany, New York

Research Site, Bronx, New York

Research Site, East Syracuse, New York

Research Site, New Hyde Park, New York

Research Site, New York, New York

Research Site, Shirley, New York

Research Site, Syracuse, New York

Research Site, Durham, North Carolina

Research Site, Fayetteville, North Carolina

Research Site, Cincinnati, Ohio

Research Site, Cleveland, Ohio

Research Site, Columbus, Ohio

Research Site, Independence, Ohio

Research Site, Wooster, Ohio

Research Site, Florence, Oregon

Research Site, Portland, Oregon

Research Site, Bala-Cynwyd, Pennsylvania

Research Site, Philadelphia, Pennsylvania

Research Site, Pittsburgh, Pennsylvania

Research Site, York, Pennsylvania

Research Site, Providence, Rhode Island

Research Site, Myrtle Beach, South Carolina

Research Site, North Charleston, South Carolina

Research Site, Sioux Falls, South Dakota

Research Site, Germantown, Tennessee

Research Site, Nashville, Tennessee

Research Site, Dallas, Texas

Research Site, Denton, Texas

Research Site, Flower Mound, Texas

Research Site, Grapevine, Texas

Research Site, Houston, Texas

Research Site, Plano, Texas

Research Site, San Antonio, Texas

Research Site, Sugar Land, Texas

Research Site, Tyler, Texas

Research Site, Wichita Falls, Texas

Research Site, Saint George, Utah

Research Site, Salt Lake City, Utah

Research Site, Fairfax, Virginia

Research Site, Winchester, Virginia

Research Site, Spokane Valley, Washington

Research Site, Spokane, Washington

Research Site, Tacoma, Washington

Research Site, Chermside, Not set

Research Site, Darlinghurst, Not set

Research Site, Hyde Park, Not set

Research Site, Kurralta Park, Not set

Research Site, Melbourne, Not set

Research Site, Randwick, Not set

Research Site, South Brisbane, Not set

Research Site, Graz, Not set

Research Site, Innsbruck, Not set

Research Site, Krems an der Donau, Not set

Research Site, Linz, Not set

Research Site, Wien, Not set

Research Site, Charleroi, Not set

Research Site, Gent, Not set

Research Site, Kortrijk, Not set

Research Site, Leuven, Not set

Research Site, Curitiba, Not set

Research Site, Pelotas, Not set

Research Site, Porto Alegre, Not set

Research Site, Rio de Janeiro, Not set

Research Site, Salvador, Not set

Research Site, Sao Luis, Not set

Research Site, Sao Paulo, Not set

Research Site, São Paulo, Not set

Research Site, Calgary, Alberta

Research Site, Edmonton, Alberta

Research Site, Abbotsford, British Columbia

Research Site, Kelowna, British Columbia

Research Site, Vancouver, British Columbia

Research Site, Winnipeg, Manitoba

Research Site, Halifax, Nova Scotia

Research Site, Kingston, Ontario

Research Site, London, Ontario

Research Site, Mississauga, Ontario

Research Site, Newmarket, Ontario

Research Site, Ottawa, Ontario

Research Site, Toronto, Ontario

Research Site, Chicoutimi, Quebec

Research Site, Greenfield Park, Quebec

Research Site, Montreal, Quebec

Research Site, Montréal, Quebec

Research Site, Saskatoon, Saskatchewan

Research Site, Quebec, Not set

Research Site, Concepcion, Not set

Research Site, La Serena, Not set

Research Site, Santiago, Not set

Research Site, Temuco, Not set

Research Site, Viña del Mar, Not set

Research Site, Beijing, Not set

Research Site, Changchun, Not set

Research Site, Changsha, Not set

Research Site, Chengdu, Not set

Research Site, Chongqing, Not set

Research Site, Dongguan, Not set

Research Site, Guangzhou, Not set

Research Site, Guilin, Not set

Research Site, Hangzhou, Not set

Research Site, Harbin, Not set

Research Site, Jiaxing, Not set

Research Site, Jinan, Not set

Research Site, Lanzhou, Not set

Research Site, Nanchang, Not set

Research Site, Nanjing, Not set

Research Site, Nantong, Not set

Research Site, Ningbo, Not set

Research Site, Shandong, Not set

Research Site, Shanghai, Not set

Research Site, Shenyang, Not set

Research Site, Suining, Not set

Research Site, Taiyuan, Not set

Research Site, Tianjin, Not set

Research Site, Weifang, Not set

Research Site, Wenzhou, Not set

Research Site, Wuhan, Not set

Research Site, Xi'an, Not set

Research Site, Yantai, Not set

Research Site, Zhengzhou, Not set

Research Site, Helsinki, Not set

Research Site, Tampere, Not set

Research Site, Turku, Not set

Research Site, Angers, Not set

Research Site, Bayonne, Not set

Research Site, Bordeaux Cedex, Not set

Research Site, Caen Cedex 5, Not set

Research Site, Clermont Ferrand, Not set

Research Site, Creteil, Not set

Research Site, Lyon, Not set

Research Site, Montpellier, Not set

Research Site, Nice, Not set

Research Site, Nîmes, Not set

Research Site, Paris, Not set

Research Site, Pierre Bénite, Not set

Research Site, Poitiers Cedex, Not set

Research Site, Quimper Cedex, Not set

Research Site, Rennes Cedex 9, Not set

Research Site, Strasbourg, Not set

Research Site, Tours, Not set

Research Site, Vandoeuvre les Nancy, Not set

Research Site, Bergisch Gladbach, Not set

Research Site, Berlin, Not set

Research Site, Bonn, Not set

Research Site, Braunschweig, Not set

Research Site, Dresden, Not set

Research Site, Duisburg, Not set

Research Site, Erlangen, Not set

Research Site, Frankfurt am Main, Not set

Research Site, Frankfurt, Not set

Research Site, Freiburg, Not set

Research Site, Göttingen, Not set

Research Site, Hamburg, Not set

Research Site, Heidelberg, Not set

Research Site, Herne, Not set

Research Site, Homburg, Not set

Research Site, Köln, Not set

Research Site, Magdeburg, Not set

Research Site, Mannheim, Not set

Research Site, Marburg, Not set

Research Site, Mettmann, Not set

Research Site, München, Not set

Research Site, Münster, Not set

Research Site, Nürtingen, Not set

Research Site, Oldenburg, Not set

Research Site, Regensburg, Not set

Research Site, Stuttgart, Not set

Research Site, Trier, Not set

Research Site, Tübingen, Not set

Research Site, Ulm, Not set

Research Site, Budapest, Not set

Research Site, Debrecen, Not set

Research Site, Győr, Not set

Research Site, Miskolc, Not set

Research Site, Nyíregyháza, Not set

Research Site, Szeged, Not set

Research Site, Szekszárd, Not set

Research Site, Bangalore, Not set

Research Site, Calicut, Not set

Research Site, Delhi, Not set

Research Site, Hyderabad, Not set

Research Site, JAipur, Not set

Research Site, Kanpur, Not set

Research Site, Kolkata, Not set

Research Site, Mohali, Not set

Research Site, Nagpur, Not set

Research Site, New Delhi, Not set

Research Site, Pune, Not set

Research Site, Surat, Not set

Research Site, Vadodara, Not set

Research Site, Varanasi, Not set

Research Site, Bari, Not set

Research Site, Genoa, Not set

Research Site, Meldola, Not set

Research Site, Milano, Not set

Research Site, Napoli, Not set

Research Site, Padova, Not set

Research Site, Rome, Not set

Research Site, Rozzano, Not set

Research Site, Terni, Not set

Research Site, Trento, Not set

Research Site, Chiba-shi, Not set

Research Site, Fukuoka-shi, Not set

Research Site, Fukuoka, Not set

Research Site, Hirakata-shi, Not set

Research Site, Hirosaki-shi, Not set

Research Site, Kanazawa-shi, Not set

Research Site, Kashihara-shi, Not set

Research Site, Kawagoe-shi, Not set

Research Site, Kisarazu-shi, Not set

Research Site, Kita-gun, Not set

Research Site, Kobe-shi, Not set

Research Site, Kumamoto-shi, Not set

Research Site, Kyoto-shi, Not set

Research Site, Maebashi-shi, Not set

Research Site, Nagano-shi, Not set

Research Site, Nagasaki-shi, Not set

Research Site, Nagoya-shi, Not set

Research Site, Nagoya, Not set

Research Site, Osaka-shi, Not set

Research Site, Osakasayama-shi, Not set

Research Site, Sagamihara-shi, Not set

Research Site, Sakura-shi, Not set

Research Site, Sapporo-shi, Not set

Research Site, Shiwa-gun, Not set

Research Site, Suita-shi, Not set

Research Site, Tsu-shi, Not set

Research Site, Yokohama-shi, Not set

Research Site, Yufu-shi, Not set

Research Site, Daejeon, Not set

Research Site, Seongnam-si, Not set

Research Site, Seoul, Not set

Research Site, Suwon, Not set

Research Site, George Town, Not set

Research Site, Johor Bahru, Not set

Research Site, Kota Kinabalu, Not set

Research Site, Kuala Lumpur, Not set

Research Site, Kuching, Not set

Research Site, Amsterdam, Not set

Research Site, Hilversum, Not set

Research Site, Nijmegen, Not set

Research Site, Arequipa, Not set

Research Site, Bellavista, Not set

Research Site, Lima, Not set

Research Site, Bydgoszcz, Not set

Research Site, Koszalin, Not set

Research Site, Poznań, Not set

Research Site, Rzeszów, Not set

Research Site, Szczecin, Not set

Research Site, Warszawa, Not set

Research Site, Wrocław, Not set

Research Site, Żory, Not set

Research Site, San Juan, Not set

Research Site, Barcelona, Not set

Research Site, Córdoba, Not set

Research Site, L'Hospitalet de Llobregat, Not set

Research Site, Lugo, Not set

Research Site, Madrid, Not set

Research Site, Sabadell, Not set

Research Site, Valencia, Not set

Research Site, Göteborg, Not set

Research Site, Malmo, Not set

Research Site, Solna, Not set

Research Site, Stockholm, Not set

Research Site, Kaohsiung, Not set

Research Site, Taichung, Not set

Research Site, Taoyuan, Not set

Research Site, Yung Kang City, Not set

Research Site, Bangkok, Not set

Research Site, Chiang Mai, Not set

Research Site, Khlong Luang, Not set

Research Site, Songkla, Not set

Research Site, Ankara, Not set

Research Site, Bornova-Izmir, Not set

Research Site, Fatih-Istanbul, Not set

Research Site, Istanbul, Not set

Research Site, Karsiyaka, Not set

Research Site, Aberdeen, Not set

Research Site, Birmingham, Not set

Research Site, Cambridge, Not set

Research Site, Glasgow, Not set

Research Site, Guildford, Not set

Research Site, London, Not set

Research Site, Manchester, Not set

Research Site, Newcastle upon Tyne, Not set

Research Site, Oxford, Not set

Research Site, Plymouth, Not set

Research Site, Preston, Not set

Research Site, Swansea, Not set

Research Site, Truro, Not set

Conditions: Metastatic Castration-Sensitive Prostate Cancer

Learn More ›